RECENT COMMENTS

Rajesh Kumar: Is it helpfull for Overian cancer patient at advance stage? Rajesh Kumar +919681303310   »Read more

Cindy: I'm not a medical professional. My mother has been diagnosed with CUP - and was treated several year [...]   »Read more

Rajesh Kumar: +919681303310.   »Read more

Rajesh Kumar: Please write your comment here   »Read more

christian: Is gabapentin has been proposed to treat peripheric neuropathy induced by chemotherapy. At low dosa [...]   »Read more

 

Article type: Editorial

Keywords: survival, quality of life, .

This article has 0 comments

Facebook Twitter Share - Send - Print - Pdf

 

Our responsibility to survivors

Our responsibility
to survivors

According to the media version, an individual who develops cancer embarks on a ‘battle’ – those who win are cured, while those who lose die. This simplistic story overlooks the many whose cancer is brought under control rather than cured, as cancer becomes more like a chronic disease. You do not, after all, fight a battle against heart disease, and the media do not present heart patients in terms of winners and losers. But even if we accept the premise of cancer as a battle, then not all survivors celebrate victory. Some have been dreadfully traumatised, not so much by the cancer as by the cure.

» Kathy Redmond

To read the complete article please click on the pdf icon

 
COMMENTS (0)
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.

ESO reserves the absolute right not to publish comments.
  Name (required)
  E-mail (will not be published) (required)
  Captcha code (required)

CancerWorld invites you to visit:

 
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.